Furthermore, incretin-based therapies can also improve mitochondrial function and reduce apoptosis by increasing anti-apoptotic protein Bcl-2 expression and lowering pro-apoptotic BAX signaling, thereby promoting neuronal survival in dopaminergic cell lines ( GLP-1 receptor agonists (e.g., exenatide, liraglutide, lixisenatide) and dual GLP-1/GIP agonists (e.g., tirzepatide) have been also reported to reduce microglial and astrocytic hyperactivation and suppress the release of inflammatory mediators such as TNF-, IL-1, and NF-B
Ballaststoffe verlangsamen die Glukoseaufnahme, nhren die Darmflora und frdern eine regelmige Verdauung
Yellow Card Report a side effect or safety concern
doi:10.1001/jama.296.1.87 [PubMed] [Crosslink] Yuan L, Kaplowitz N
Menthol A compound obtained from peppermint oil or other mint oils
How does L Carnitine work